Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 1;7(9):e2349.
doi: 10.1038/cddis.2016.254.

Nitric oxide released from JS-K induces cell death by mitotic catastrophe as part of necrosis in glioblastoma multiforme

Affiliations

Nitric oxide released from JS-K induces cell death by mitotic catastrophe as part of necrosis in glioblastoma multiforme

Jessica Günzle et al. Cell Death Dis. .

Abstract

The nitric oxide (NO) donor JS-K is specifically activated by glutathione S-transferases (GSTs) in GST-overexpressing cells. We have shown the induction of cell death in glioblastoma multiforme (GBM) cells at high JS-K doses but the mechanism remains unclear. The aim of this study was to determine whether NO-induced cell death is triggered by induction of apoptotic or necrotic pathways. For the first time, we demonstrate that NO induces cell death via mitotic catastrophe (MC) with non-apoptotic mechanisms in GBM cells. Moreover, the level of morphological changes indicating MC correlates with increased necrosis. Therefore, we conclude that MC is the main mechanism by which GBM cells undergo cell death after treatment with JS-K associated with necrosis rather than apoptosis. In addition, we show that PARP1 is not an exclusive marker for late apoptosis but is also involved in MC. Activating an alternative way of cell death can be useful for the multimodal cancer therapy of GBM known for its strong anti-apoptotic mechanisms and drug resistance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cytotoxic effect of JS-K (1–25 μM) and DMSO control (0,  48%) on U87, LN229 and primary IC cells after 48 h (a) and 72 h (b). Cell viability was determined by MTT assay at the end of the incubation time. Cytotoxicity induced by JS-K was plotted relative to viability of untreated controls set to 100% (±s.d. of three independent experiments). Asterisks (*P<0.05, **P<0.01, ***P<0.001) indicate significance between JS-K and controls
Figure 2
Figure 2
Western blot analysis for caspases 9 and 3, cleaved caspases 9 and 8 (cCaspase), PARP1 and cleaved PARP1 (cPARP1) in U87 (a), IC (b) and LN229 (c) cells after 48 h and 72 h exposure of JS-K (1–5 μM). 25 μg of protein lysates were separated with SDS-PAGE and probed with the different antibodies. Caspase 9 and 8 are expressed and cleaved equally in all three cell lines and both in untreated and DMSO controls. No cleavage and no decrease in protein level of caspase 3 can be shown. The figures shown are representative for three independent experiments
Figure 3
Figure 3
Dose-dependent increase of intracellular cGMP in U87 (a) and LN229 (b) cells mediated by JS-K after 48 h as well as in necrotic controls exposed to H2O2 (3 mM). cGMP level remained stable after induction of apoptosis by etoposide (10 μM). Asterisks (*P<0.05, **P<0.01, ***P<0.001) indicate significance compared to untreated controls. Western blot analysis for pAkt in LN229 (c) cells show increase of phosphorylation after exposure to JS-K for 48 h compared to control. The blot is representative for three independent experiments
Figure 4
Figure 4
Dose- and time-dependent decrease of intracellular ATP level in U87 (a), IC (b) and LN229 (c) cells after exposure to JS-K for 48 and 72 h. ATP level increased after treatment with etoposide (10 μM) in U87 (a) and LN229 (c) and decreased by H2O2 (3 mM) after 4 h exposure in all three cell lines. Mean values±s.d. of three independent experiments are plotted. Asterisks (*P<0.05, **P<0.01, ***P<0.001) indicate significance between JS-K and untreated controls
Figure 5
Figure 5
Flow cytometry analysis of annexin V and PI in U87 (a), IC (b) and LN229 (c) cells exposed to JS-K for 48 and 72 h and both untreated and DMSO-controls. 2 × 104 cells were analysed by FACSCalibur and show significant increase of necrotic cell population. Treatment groups were normalized to total cell number and plotted relative to untreated controls±s.d. of three independent experiments. Asterisks (*P<0.05, **P<0.01, ***P<0.001) indicate significance between apoptotic and necrotic population
Figure 6
Figure 6
Figures show MC induced by JS-K (1–10 μM) in U87, IC and LN229 cells after 48 and 72 h. Characteristics of MC are indicated with asterisk as example for 10 μM JS-K after 48 h. Samples were analysed by microscopy (40 ×, scale bar represent 25 μm). Data are representative for three independent experiments
Figure 7
Figure 7
Quantitative analysis of TUNEL and MC in U87 (a), IC (b) and LN229 (c) cells after exposure to JS-K for 48 and 72 h. The induction of MC was determined by counting cells with characteristics described by Roninson et al. Induction of cell death by JS-K was plotted relative to total cell number and show a significant dose- and time-dependent increase in MC compared to apoptosis. Asterisks (*P<0.05, **P<0.01, ***P<0.001) indicate significance between apoptosis and MC with ±s.d. of three independent experiments

Similar articles

Cited by

References

    1. Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 2008; 27: 2783–2802. - PMC - PubMed
    1. Weyerbrock A, Walbridge S, Saavedra JE, Keefer LK, Oldfield EH. Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas. Neuro Oncol 2011; 13: 203–211. - PMC - PubMed
    1. Kogias E, Osterberg N, Baumer B, Psarras N, Koentges C, Papazoglou A et al. Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas. Int J Cancer 2012; 130: 1184–1194. - PMC - PubMed
    1. Shami PJ, Maciag AE, Eddington JK, Udupi V, Kosak KM, Saavedra JE et al. JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C). Leuk Res 2009; 33: 1525–1529. - PMC - PubMed
    1. Contestabile A, Ciani E. Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation. Neurochem Int 2004; 45: 903–914. - PubMed

MeSH terms